By Josh Beckerman
Shares of Definitive Healthcare, which provides data and analytics about the healthcare sector, fell to a 52-week low after the company reported fourth-quarter results and projected lower 2025 revenue.
The stock was recently down 39% to $3 Friday and is down about 27% this year. Its intraday low was $2.58.
Quarterly revenue was down 6% to $62.3 million. Adjusted net income rose to $12.6 million from $10.6 million. Definitive Healthcare expects revenue of $230 million to $240 million this year, down from $252.2 million in 2024.
Stifel Financial said the company's client churn "accelerated in the quarter and will remain elevated into 1Q," but said it is encouraged by various actions to reduce churn and improve the platform. It said the stock is "range-bound, pending improving data points."
The company also said Casey Heller, senior vice president of finance, will become chief financial officer effective June 2, succeeding Rick Booth, who has been CFO since March 2021.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
February 28, 2025 13:43 ET (18:43 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.